BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37777287)

  • 1. All-cause hospitalisation among people living with HIV according to gender, mode of HIV acquisition, ethnicity, and geographical origin in Europe and North America: findings from the ART-CC cohort collaboration.
    Rein SM; Lampe FC; Ingle SM; Sterne JAC; Trickey A; Gill MJ; Papastamopoulos V; Wittkop L; van der Valk M; Kitchen M; Guest JL; Satre DD; Wandeler G; Galindo P; Castilho J; Crane HM; Smith CJ
    Lancet Public Health; 2023 Oct; 8(10):e776-e787. PubMed ID: 37777287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies.
    Trickey A; McGinnis K; Gill MJ; Abgrall S; Berenguer J; Wyen C; Hessamfar M; Reiss P; Kusejko K; Silverberg MJ; Imaz A; Teira R; d'Arminio Monforte A; Zangerle R; Guest JL; Papastamopoulos V; Crane H; Sterling TR; Grabar S; Ingle SM; Sterne JAC
    Lancet HIV; 2024 Mar; 11(3):e176-e185. PubMed ID: 38280393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study.
    Trickey A; Zhang L; Gill MJ; Bonnet F; Burkholder G; Castagna A; Cavassini M; Cichon P; Crane H; Domingo P; Grabar S; Guest J; Obel N; Psichogiou M; Rava M; Reiss P; Rentsch CT; Riera M; Schuettfort G; Silverberg MJ; Smith C; Stecher M; Sterling TR; Ingle SM; Sabin CA; Sterne JAC
    Lancet HIV; 2022 Jun; 9(6):e404-e413. PubMed ID: 35659335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality in migrants living with HIV in western Europe (1997-2013): a collaborative cohort study.
    Migrants Working Group on behalf of COHERE in EuroCoord
    Lancet HIV; 2015 Dec; 2(12):e540-9. PubMed ID: 26614968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. All-cause hospitalization according to demographic group in people living with HIV in the current antiretroviral therapy era.
    Rein SM; Lampe FC; Johnson MA; Bhagani S; Miller RF; Chaloner C; Phillips AN; Burns FM; Smith CJ
    AIDS; 2021 Feb; 35(2):245-255. PubMed ID: 33170817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies.
    Trickey A; Sabin CA; Burkholder G; Crane H; d'Arminio Monforte A; Egger M; Gill MJ; Grabar S; Guest JL; Jarrin I; Lampe FC; Obel N; Reyes JM; Stephan C; Sterling TR; Teira R; Touloumi G; Wasmuth JC; Wit F; Wittkop L; Zangerle R; Silverberg MJ; Justice A; Sterne JAC
    Lancet HIV; 2023 May; 10(5):e295-e307. PubMed ID: 36958365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies.
    Boulle A; Schomaker M; May MT; Hogg RS; Shepherd BE; Monge S; Keiser O; Lampe FC; Giddy J; Ndirangu J; Garone D; Fox M; Ingle SM; Reiss P; Dabis F; Costagliola D; Castagna A; Ehren K; Campbell C; Gill MJ; Saag M; Justice AC; Guest J; Crane HM; Egger M; Sterne JA
    PLoS Med; 2014 Sep; 11(9):e1001718. PubMed ID: 25203931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study.
    ; Lodwick RK; Sabin CA; Porter K; Ledergerber B; van Sighem A; Cozzi-Lepri A; Khaykin P; Mocroft A; Jacobson L; De Wit S; Obel N; Castagna A; Wasmuth JC; Gill J; Klein MB; Gange S; Riera M; Mussini C; Gutiérrez F; Touloumi G; Carrieri P; Guest JL; Brockmeyer NH; Phillips AN
    Lancet; 2010 Jul; 376(9738):340-5. PubMed ID: 20638118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of geographical origin and ethnicity on mortality in patients on antiretroviral therapy in Canada, Europe, and the United States.
    Antiretroviral Therapy Cohort Collaboration (ART-CC)
    Clin Infect Dis; 2013 Jun; 56(12):1800-9. PubMed ID: 23457077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study.
    Althoff KN; Stewart C; Humes E; Gerace L; Boyd C; Gebo K; Justice AC; Hyle EP; Coburn SB; Lang R; Silverberg MJ; Horberg MA; Lima VD; Gill MJ; Karris M; Rebeiro PF; Thorne J; Rich AJ; Crane H; Kitahata M; Rubtsova A; Wong C; Leng S; Marconi VC; D'Souza G; Kim HN; Napravnik S; McGinnis K; Kirk GD; Sterling TR; Moore RD; Kasaie P
    PLoS Med; 2024 Jan; 21(1):e1004325. PubMed ID: 38215160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV risk behaviours among immigrant and ethnic minority gay and bisexual men in North America and Europe: A systematic review.
    Lewis NM; Wilson K
    Soc Sci Med; 2017 Apr; 179():115-128. PubMed ID: 28260636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC).
    May MT; Ingle SM; Costagliola D; Justice AC; de Wolf F; Cavassini M; D'Arminio Monforte A; Casabona J; Hogg RS; Mocroft A; Lampe FC; Dabis F; Fätkenheuer G; Sterling TR; del Amo J; Gill MJ; Crane HM; Saag MS; Guest J; Brodt HR; Sterne JA;
    Int J Epidemiol; 2014 Jun; 43(3):691-702. PubMed ID: 23599235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US.
    Antiretroviral Therapy Cohort Collaboration (ART-CC)
    Antivir Ther; 2015; 20(1):21-8. PubMed ID: 24675571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cancer risk in women living with HIV across four continents: A multicohort study.
    Rohner E; Bütikofer L; Schmidlin K; Sengayi M; Maskew M; Giddy J; Taghavi K; Moore RD; Goedert JJ; Gill MJ; Silverberg MJ; D'Souza G; Patel P; Castilho JL; Ross J; Sohn A; Bani-Sadr F; Taylor N; Paparizos V; Bonnet F; Verbon A; Vehreschild JJ; Post FA; Sabin C; Mocroft A; Dronda F; Obel N; Grabar S; Spagnuolo V; Quiros-Roldan E; Mussini C; Miro JM; Meyer L; Hasse B; Konopnicki D; Roca B; Barger D; Clifford GM; Franceschi S; Egger M; Bohlius J
    Int J Cancer; 2020 Feb; 146(3):601-609. PubMed ID: 31215037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All-cause mortality after antiretroviral therapy initiation in HIV-positive women from Europe, Sub-Saharan Africa and the Americas.
    AIDS; 2020 Feb; 34(2):277-289. PubMed ID: 31876592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics.
    May MT; Hogg RS; Justice AC; Shepherd BE; Costagliola D; Ledergerber B; Thiébaut R; Gill MJ; Kirk O; van Sighem A; Saag MS; Navarro G; Sobrino-Vegas P; Lampe F; Ingle S; Guest JL; Crane HM; D'Arminio Monforte A; Vehreschild JJ; Sterne JA;
    Int J Epidemiol; 2012 Dec; 41(6):1807-20. PubMed ID: 23148105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.
    Mayer KH; Molina JM; Thompson MA; Anderson PL; Mounzer KC; De Wet JJ; DeJesus E; Jessen H; Grant RM; Ruane PJ; Wong P; Ebrahimi R; Zhong L; Mathias A; Callebaut C; Collins SE; Das M; McCallister S; Brainard DM; Brinson C; Clarke A; Coll P; Post FA; Hare CB
    Lancet; 2020 Jul; 396(10246):239-254. PubMed ID: 32711800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of virological suppression and rebound between Indigenous and non-Indigenous persons initiating combination antiretroviral therapy in a multisite cohort of individuals living with HIV in Canada.
    Benoit AC; Younger J; Beaver K; Jackson R; Loutfy M; Masching R; Nobis T; Nowgesic E; O'Brien-Teengs D; Whitebird W; Zoccole A; Hull M; Jaworsky D; Rachlis A; Rourke S; Burchell AN; Cooper C; Hogg R; Klein MB; Machouf N; Montaner J; Tsoukas C; Raboud J; ;
    Antivir Ther; 2017; 22(4):325-335. PubMed ID: 27925609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?
    Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord
    HIV Med; 2018 Jan; 19(1):42-48. PubMed ID: 28741837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients.
    Ingle SM; May MT; Gill MJ; Mugavero MJ; Lewden C; Abgrall S; Fätkenheuer G; Reiss P; Saag MS; Manzardo C; Grabar S; Bruyand M; Moore D; Mocroft A; Sterling TR; D'Arminio Monforte A; Hernando V; Teira R; Guest J; Cavassini M; Crane HM; Sterne JA;
    Clin Infect Dis; 2014 Jul; 59(2):287-97. PubMed ID: 24771333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.